✦ LIBER ✦

Prognostic factors for allogeneic stem cell transplantation (ASCT) for untreated first relapse of acute myeloid leukemia (AML)/myelodysplastic syndrome (MDS)

✍ Scribed by J.G. Alamo; M. Shahjahan; R.S. Wong; M. de Lima; I. Khouri; J. Gajewski; D. Couriel; B.S. Andersson; P. Anderlini; R. Champlin; S. Giralt

Book ID: 116278068
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 74 KB
Volume: 11
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2004.12.112

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lack of impact of comorbidities on outco

Lack of impact of comorbidities on outcomes of allogeneic stem cell transplantation (ASCT) for refractory acute myeloid leukemia (AML)/myelodysplastic syndrome (MDS)

✍ R.S. Wong; M. Shahjahan; J. Alamo; M. de Lima; I. Khouri; J. Gajewski; B. Anders 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 63 KB

59: GM-CSF secreting leukemia cell vacci

59: GM-CSF secreting leukemia cell vaccinations after allogeneic reduced-intensity peripheral blood stem cell transplantation (SCT) for advanced myelodysplastic syndrome (MDS) or refractory acute myeloid leukemia (AML)

✍ V.T. Ho; G. Dranoff; H. Kim; M. Pasek; C. Cutler; J. Koreth; E.P. Alyea; J.H. An 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Allogeneic hematopoietic stem cell trans

Allogeneic hematopoietic stem cell transplantation (HSCT) for high-risk acute myeloid leukemia (AML)/myelodysplastic syndrome (MDS): How can we improve outcomes in the near future?

✍ Gordon L. Phillips 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 325 KB

Relapse after Allogeneic Hematopoietic S

Relapse after Allogeneic Hematopoietic Stem Cell Transplantation (HCT) for Acute Myeloid Leukemia (AML)/Myelodysplastic Syndrome (MDS) Following Intravenous Busulfan Plus Fludarabine Based Conditioning: Outcomes and Monocyte Chemo-Attractant Protein -1

✍ Khaled, Yasser; Solh, Melhem; Fondaw, Megan; Lamontagne, Deborah; Batista, Angin 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 239 KB

Allogeneic Stem Cell Transplantation in

Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia in First or Subsequent Remission: Weighing Prognostic Markers Predicting Relapse and Risk Factors for Non-relapse Mortality

✍ Ellen Meijer; Jan J. Cornelissen 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 127 KB

Autologous stem cell transplantation (AS

Autologous stem cell transplantation (ASCT) in untreated first relapse (REL1) or following re-induction chemotherapy (CT) for patients (pts) with acute myelogenous leukemia (AML)

✍ R. Pornvipavee; R.A. Dierkhising; M.A. Elliott; W.J. Hogan; W.K. Kremers; L. Let 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 59 KB